炎症性肠病患者Roux-en-Y胃旁路术与袖状胃切除术的短期结局比较
结果显示RYGB后CD患者IBD药物需求加重的比例显著高于SG(37.5% vs 4%;p=0.016),且RYGB手术并发症率更高(26% vs 3%;p=0.02)。对于IBD尤其是CD患者,SG可能是更安全的选择。
要点
- RYGB后CD患者IBD药物需求加重比例显著高于SG(37.5% vs 4%;p=0.016)。
- RYGB手术并发症率显著高于SG(26% vs 3%;p=0.02)。
- IBD尤其是CD患者行减重手术时,SG可能是更安全的选择。
核心结论
- IBD患者减重术后相当比例IBD病情改善,但CD患者RYGB后IBD药物需求加重比例显著高于SG。
- SG减重效果略逊于RYGB,但严重并发症率更低;IBD尤其是CD患者SG可能更安全。
研究设计与样本
- 回顾性队列研究,纳入2000至2017年间术前已诊断IBD的54例减重手术患者。
主要发现
- RYGB与SG患者年龄(46.2±9.5岁 vs 47.2±12.3岁)和术前BMI(48.5±7.7 kg/m2 vs 44.9±7.3 kg/m2)相似。
- 两种术式术后1年均实现显著体重下降。
- UC患者IBD药物需求改善(27% vs 8%)、不变(64% vs 92%)、加重(9% vs 0%)比例在RYGB与SG间无显著差异。
- CD患者IBD药物需求改善(37.5% vs 44%)、不变(25% vs 52%)比例在RYGB与SG间无显著差异。
- CD患者IBD药物需求加重比例RYGB显著高于SG(37.5% vs 4%;p=0.016),RYGB手术并发症率也显著高于SG(26% vs 3%;p=0.02)。
临床怎么用
- 对合并IBD的减重手术患者,尤其CD患者,优先考虑SG以降低IBD药物需求加重和手术并发症风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) are the most effective therapies for obesity and may have beneficial effects on the immune system. Therefore, we compared RYGB vs SG outcomes in patients with inflammatory bowel disease (IBD). STUDY DESIGN: In this retrospective cohort study, we identified 54 patients with either Crohn's disease (CD; n = 31) or ulcerative colitis (UC; n = 23), diagnosed before bariatric surgery, between 2000 and 2017. Nineteen patients underwent RYGB and 35 patients underwent SG. RESULTS: Patients presenting for RYGB and SG were of similar age (46.2 ± 9.5 years vs 47.2 ± 12.3 years), preoperative BMI (48.5 ± 7.7 kg/m2 vs 44.9 ± 7.3 kg/m2) and IBD status, as measured by medications. Both operations led to significant weight loss at 1 year. After RYGB and SG, there were no significant differences in the proportion of patients with UC who had improved (27% vs 8%), unchanged (64% vs 92%), or worse (9% vs 0%) IBD medication requirements, respectively. Similar analysis in the patients with CD showed no significant differences in the proportion who had improved (37.5% vs 44%), or unchanged (25% vs 52%) IBD-medication requirements after RYGB and SG, respectively. However, there was a significant difference in the proportion of patients who had worsened CD after RYGB compared with SG (37.5% vs 4%; p = 0.016). There was a greater rate of surgical complications after RYGB compared to SG (26% vs. 3%; p = 0.02). CONCLUSIONS: A sizable proportion of patients experienced improvements in IBD post-bariatric surgery. However, in CD patients, RYGB was associated with a significantly greater number of patients with increased IBD-medication requirements. Sleeve gastrectomy led to less weight loss, but had a lower rate of severe complications compared with RYGB. In patients with IBD, and particularly CD, SG may be the safer surgery.
引用
- Heshmati K, Lo T, Tavakkoli A, et al. Short-Term Outcomes of Inflammatory Bowel Disease after Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy. J Am Coll Surg. 2019. PMID: 30797083. doi:10.1016/j.jamcollsurg.2019.01.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。